Cargando…
Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting
BACKGROUND: Varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, is a pharmacotherapy indicated for smoking cessation treatment. To our knowledge, no studies have described varenicline treatment adherence and efficacy from real-world treatment patterns in a U.S. primary ca...
Autores principales: | Liberman, Joshua N., Lichtenfeld, Marc J., Galaznik, Aaron, Mastey, Vera, Harnett, James, Zou, Kelly H., Leader, Joseph B., Kirchner, H. Lester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437765/ https://www.ncbi.nlm.nih.gov/pubmed/23461428 http://dx.doi.org/10.18553/jmcp.2013.19.2.125 |
Ejemplares similares
-
Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
por: Galaznik, Aaron, et al.
Publicado: (2014) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009)